.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
Argus Health
Farmers Insurance
Merck
Cantor Fitzgerald
Cipla
Chinese Patent Office
US Department of Justice
AstraZeneca

Generated: February 18, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0123571

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis UsAUBAGIOteriflunomideTABLET;ORAL202992-001Sep 12, 2012RXYesNo➤ Try a Free Trial➤ Try a Free TrialTREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
Sanofi Aventis UsAUBAGIOteriflunomideTABLET;ORAL202992-002Sep 12, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist